Ryan C Ungaro, MD
- ASSOCIATE PROFESSOR | Medicine, Gastroenterology
Specialties:Gastroenterology, Internal Medicine
Research Topic:Inflammatory Bowel Disease (IBD)
Dr. Ryan Ungaro is an Associate Professor of Medicine in the Division of Gastroenterology at the Icahn School of Medicine at Mount Sinai. Dr. Ungaro received his medical degree from the Icahn School of Medicine at Mount Sinai where he graduated Alpha Omega Alpha and with Distinction in Research. He completed his internal medicine training and served as chief resident at the Mount Sinai Medical Center then went on to complete fellowship training in gastroenterology at the Mount Sinai Medical Center and served as chief gastroenterology fellow. Dr. Ungaro received training in translational inflammatory bowel disease (IBD) research as a Howard Hughes Medical Institute Research Fellow and completed a Masters in Biostatistics and Clinical Research Methods at Columbia University Mailman School of Public Health.
Dr. Ungaro specializes in the care of patients with ulcerative colitis and Crohn's disease. He is Director of the Comprehensive Care for the Recently Diagnosed IBD Patient (COMPASS-IBD) Program at the Susan and Leonard Feinstein IBD Clinical Center. This program provides interdisciplinary care for recently diagnosed IBD patients. His research focuses on understanding early IBD including the impact of early intervention on IBD outcomes and precision medicine approaches to improve risk stratification and optimization of therapy for recently diagnosed IBD patients. His research has been supported by an NIH K23 Career Development Award and a Crohn's and Colitis Foundation Career Development Award.
In addition, Dr. Ungaro is co-founder of the Surveillance Epidemiology of Coronavirus Under Research Exclusion (SECURE-IBD) web-based registry. SECURE-IBD is an international collaboration that has been recognized as a leading source of data to guide IBD management in the COVID-19 era.
Dr. Ungaro has also served on the American Gastroenterological Association (AGA) Research Awards Panel and as Co-Chair of the Crohn's and Colitis Foundation Rising Educators Academics and Clinicians Helping IBD (REACH-IBD) committee. He has received various distinctions including being selected for the AGA Future Leaders Program, the Eric R. Lemmer Memorial Award, the Crohn’s and Colitis Foundation Greater New York Chapter Take Steps Health Care Honored Hero, and the Cullman Family Award for Excellence in Physician Communication.
- Antibiotic-Associated Colitis-C Difficile
- Celiac Disease
- Colon Polyps
- Crohn's Disease
- Inflammatory Bowel Disease
- Ulcerative Colitis
MD, Icahn School of Medicine at Mount Sinai
MS, Columbia University Mailman School of Public Health
Residency, Internal Medicine, Mount Sinai Hospital
Fellowship, Gastroenterology, Mount Sinai Hospital
Icahn School of Medicine at Mount sinai Immunotherapy Fellowship
New York Super Doctors Rising Stars
American Gastroenterological Association Future Leaders Program
Mount Sinai Department of Medicine Advisory Board Award
Eric R. Lemmer Memorial Award
Mount Sinai KL2 Scholars Awards for Clinical and translational Research Career Development Awards
Poster of Distinctions, Crohn's and Colitis Foundation Advances in Inflammatory Bowel Disease Conference
Distinguished Poster Award
National GI Jeopardy Competition Champion
Burrill B. Crohn Research Foundation Research Grant
Best Abstract Award
The Silver Apple Teaching Award
Mount Sinai Distinction in Research Award
Mount Sinai Milton C. Engel Prize in Geriatric Medicine
Alpha Omega Alpha (AOA)
Phi Beta Kappa
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Ungaro during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- AbbVie Inc.; Bristol-Myers Squibb; Eli Lilly and Company; Janssen Pharmaceuticals, Inc.; Pfizer Inc.; Takeda Pharmaceutical Company Limited
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose.
- Takeda Pharmaceutical Company Limited
Other Activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership.
- Prometheus Laboratories Inc.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.